Insights / Events
Clinion at SCDM 2025 Annual Conference

The SCDM Annual Conference 2025 concluded with remarkable vigor. From being recognized as a finalist for the prestigious SCDM Innovation Award to stirring conversations through thought leadership and live demonstrations, this year’s conference was truly memorable for us.
Key Highlights from the Event
SCDM Innovation Award Finalist
While many solutions remain at the stage of promises and prototypes, Clinion’s Multi-Agentic AI for Clinical Data Review was named a finalist for the SCDM Innovation Award, as a solution already proven in real-world production. This recognition is more than acknowledgment; it reflects the industry’s need for solutions that truly deliver on their promise.

Spotlight Session: Thought Leadership That Resonated
Our Founder & CEO, Manuj Vangipurapu, delivered a session on how Agentic AI is reshaping clinical data management – advancing from prompt-based tools to autonomous intelligence. He highlighted adoption opportunities, scaling challenges, and strategies for sustainable use, with the discussion drawing strong engagement and reaffirming AI’s central role in the future of clinical research.
The Booth Experience
Clinion’s booth thrummed with energy as our innovations took center stage. Through live demonstrations, attendees witnessed our full suite of AI-powered eClinical Platform in action, with solutions that not only simplify workflows but also redefine what is possible in clinical data management. The steady stream of curiosity and enthusiasm was a testament to the industry’s readiness to embrace transformation and its recognition of Clinion as a trailblazer.

Looking Forward
SCDM 2025 was more than an event. The response from the community reaffirmed our belief that the future belongs to REAL AI delivering REAL IMPACT. Being named a finalist for the SCDM Innovation Award was further acknowledgment of the progress we are making toward that future.
Glimpses from the conference












Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%
Compliance
Fully Compliant with Global Standards

